A single-center experience with undifferentiated embryonal sarcoma of the liver

Melissa D. Mathias, Srikanth R. Ambati, Alexander Ja-Ho Chou, Emily K. Slotkin, Leonard H. Wexler, Paul A. Meyers, Heather Magnan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.

Original languageEnglish (US)
Pages (from-to)2246-2248
Number of pages3
JournalPediatric Blood and Cancer
Volume63
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Sarcoma
Liver
Adjuvant Chemotherapy
Disease-Free Survival
Pediatrics
Neoplasms

Keywords

  • case series
  • sarcoma
  • undifferentiated embryonal sarcoma of the liver

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Mathias, M. D., Ambati, S. R., Chou, A. J-H., Slotkin, E. K., Wexler, L. H., Meyers, P. A., & Magnan, H. (2016). A single-center experience with undifferentiated embryonal sarcoma of the liver. Pediatric Blood and Cancer, 63(12), 2246-2248. https://doi.org/10.1002/pbc.26154

A single-center experience with undifferentiated embryonal sarcoma of the liver. / Mathias, Melissa D.; Ambati, Srikanth R.; Chou, Alexander Ja-Ho; Slotkin, Emily K.; Wexler, Leonard H.; Meyers, Paul A.; Magnan, Heather.

In: Pediatric Blood and Cancer, Vol. 63, No. 12, 01.12.2016, p. 2246-2248.

Research output: Contribution to journalArticle

Mathias, MD, Ambati, SR, Chou, AJ-H, Slotkin, EK, Wexler, LH, Meyers, PA & Magnan, H 2016, 'A single-center experience with undifferentiated embryonal sarcoma of the liver', Pediatric Blood and Cancer, vol. 63, no. 12, pp. 2246-2248. https://doi.org/10.1002/pbc.26154
Mathias, Melissa D. ; Ambati, Srikanth R. ; Chou, Alexander Ja-Ho ; Slotkin, Emily K. ; Wexler, Leonard H. ; Meyers, Paul A. ; Magnan, Heather. / A single-center experience with undifferentiated embryonal sarcoma of the liver. In: Pediatric Blood and Cancer. 2016 ; Vol. 63, No. 12. pp. 2246-2248.
@article{4ed46b5fb1aa4ab1886f25b022bd68b6,
title = "A single-center experience with undifferentiated embryonal sarcoma of the liver",
abstract = "Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100{\%} event-free survival.",
keywords = "case series, sarcoma, undifferentiated embryonal sarcoma of the liver",
author = "Mathias, {Melissa D.} and Ambati, {Srikanth R.} and Chou, {Alexander Ja-Ho} and Slotkin, {Emily K.} and Wexler, {Leonard H.} and Meyers, {Paul A.} and Heather Magnan",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/pbc.26154",
language = "English (US)",
volume = "63",
pages = "2246--2248",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - A single-center experience with undifferentiated embryonal sarcoma of the liver

AU - Mathias, Melissa D.

AU - Ambati, Srikanth R.

AU - Chou, Alexander Ja-Ho

AU - Slotkin, Emily K.

AU - Wexler, Leonard H.

AU - Meyers, Paul A.

AU - Magnan, Heather

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.

AB - Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.

KW - case series

KW - sarcoma

KW - undifferentiated embryonal sarcoma of the liver

UR - http://www.scopus.com/inward/record.url?scp=84994164387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994164387&partnerID=8YFLogxK

U2 - 10.1002/pbc.26154

DO - 10.1002/pbc.26154

M3 - Article

VL - 63

SP - 2246

EP - 2248

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 12

ER -